These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29446917)

  • 21. Prevention of thermally induced aggregation of IgG antibodies by noncovalent interaction with poly(acrylate) derivatives.
    Martin N; Ma D; Herbet A; Boquet D; Winnik FM; Tribet C
    Biomacromolecules; 2014 Aug; 15(8):2952-62. PubMed ID: 25019321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.
    Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R
    J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
    Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
    J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations.
    Saito S; Hasegawa J; Kobayashi N; Kishi N; Uchiyama S; Fukui K
    Pharm Res; 2012 Feb; 29(2):397-410. PubMed ID: 21853361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible NaCl-induced aggregation of a monoclonal antibody at low pH: Characterization of aggregates and factors affecting aggregation.
    Bickel F; Herold EM; Signes A; Romeijn S; Jiskoot W; Kiefer H
    Eur J Pharm Biopharm; 2016 Oct; 107():310-20. PubMed ID: 27449627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An accelerated surface-mediated stress assay of antibody instability for developability studies.
    Kopp MRG; Wolf Pérez AM; Zucca MV; Capasso Palmiero U; Friedrichsen B; Lorenzen N; Arosio P
    MAbs; 2020; 12(1):1815995. PubMed ID: 32954930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-interaction chromatography as a rapid screening technique to identify the stability of new antibody therapeutics.
    Hedberg SHM; Rapley J; Haigh JM; Williams DR
    Eur J Pharm Biopharm; 2018 Dec; 133():131-137. PubMed ID: 30316818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Native Reversible Self-Association of a Monoclonal Antibody Mediated by Fab-Fab Interaction.
    Gentiluomo L; Roessner D; Streicher W; Mahapatra S; Harris P; Frieß W
    J Pharm Sci; 2020 Jan; 109(1):443-451. PubMed ID: 31563513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cosolute effects on the chemical potential and interactions of an IgG1 monoclonal antibody at high concentrations.
    Scherer TM
    J Phys Chem B; 2013 Feb; 117(8):2254-66. PubMed ID: 23330570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregation stability of a monoclonal antibody during downstream processing.
    Arosio P; Barolo G; Müller-Späth T; Wu H; Morbidelli M
    Pharm Res; 2011 Aug; 28(8):1884-94. PubMed ID: 21448757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggregation of anti-streptavidin immunoglobulin gamma-1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration.
    Kim N; Remmele RL; Liu D; Razinkov VI; Fernandez EJ; Roberts CJ
    Biophys Chem; 2013 Feb; 172():26-36. PubMed ID: 23334430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
    Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
    MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of orthogonal NISTmAb size heterogeneity control methods.
    Turner A; Yandrofski K; Telikepalli S; King J; Heckert A; Filliben J; Ripple D; Schiel JE
    Anal Bioanal Chem; 2018 Mar; 410(8):2095-2110. PubMed ID: 29428991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlating the Effects of Antimicrobial Preservatives on Conformational Stability, Aggregation Propensity, and Backbone Flexibility of an IgG1 mAb.
    Arora J; Joshi SB; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2017 Jun; 106(6):1508-1518. PubMed ID: 28212986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of a platform process operating space for a monoclonal antibody susceptible to reversible and irreversible aggregation using a solution stability screening approach.
    Man A; Luo H; Levitskaya SV; Macapagal N; Newell KJ
    J Chromatogr A; 2019 Jul; 1597():100-108. PubMed ID: 30922716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of formulation on the stability and aerosol performance of a nebulized antibody.
    Respaud R; Marchand D; Parent C; Pelat T; Thullier P; Tournamille JF; Viaud-Massuard MC; Diot P; Si-Tahar M; Vecellio L; Heuzé-Vourc'h N
    MAbs; 2014; 6(5):1347-55. PubMed ID: 25517319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
    Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA
    Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of salts from the Hofmeister series on the conformational stability, aggregation propensity, and local flexibility of an IgG1 monoclonal antibody.
    Majumdar R; Manikwar P; Hickey JM; Samra HS; Sathish HA; Bishop SM; Middaugh CR; Volkin DB; Weis DD
    Biochemistry; 2013 May; 52(19):3376-89. PubMed ID: 23594236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.